Free Preview
For the very first time, 7investing is revealing one of our previous recommendation reports! Dicerna Pharmaceuticals was recently acquired by Novo Nordisk in a $3.3 billion deal. We're taking this opportunity to showcase some of our previous research of what we liked about the pre-commercial drug developer using RNAi to control gene expression.
